Tenuigenin promotes non-rapid eye movement sleep via the GABAA receptor and exerts somnogenic effect in a MPTP mouse model of Parkinson's disease

• Published in: Biomedicine & pharmacotherapy Vol. 165; p. 115259
• Main Authors: Zhang, Di, Zhang, Wenjing, Deng, Shumin, Liu, Lu, Wei, Hua, Xue, Fenqin, Yang, Hui, Wang, Xiaomin, Fan, Zheng
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 01.09.2023; Elsevier
• Subjects: GABAA receptor; NREM sleep; Parkinson’s diseases; Sleep disturbances; Tenuigenin; VLPO; Parkinson’s diseases; NREM sleep; GABAA receptor; Sleep disturbances; VLPO; Tenuigenin
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115259

Sleep disturbances are commonly non-motor symptoms in Parkinson's diseases (PD). However, standard dopamine replacement therapies for the treatment of motor symptoms often prove inadequate in combating sleep disturbances. Previous studies conducted by our research group have reported the neuroprotective effects of tenuigenin, a natural extract from Polygala tenuifolia root, which has been traditionally employed in treating insomnia. The objective of this study was to investigate the potential of tenuigenin in modulating sleep-wake behaviors and elucidate the underlying mechanisms. We employed EEG/EMG recordings to evaluate the impact of tenuigenin on sleep-wake profiles. Furthermore, we utilized c-Fos immunostaining, whole-cell patch clamping and local field potentials (LFP) recording to explore the mechanisms involved in sleep-promoting effects of tenuigenin. Additionally, we examined the effects of tenuigenin on sleep-promoting in MPTP PD mice. Here, we found tenuigenin demonstrated a significant increase in NREM sleep and a reduction in sleep latency in mice, without altering the EEG power density. Moreover, tenuigenin increased c-Fos expression in the ventrolateral preoptic area (VLPO) and stimulated sleep-promoting neurons in VLPO. The sleep-promoting effects of tenuigenin were abolished when mice were pretreated with flumazenil, an antagonist at the benzodiazepine site of the GABAA receptor. Furthermore, tenuigenin was found to ameliorate sleep disturbances in MPTP-induced mice. The results suggesting that tenuigenin facilitated a type of NREM sleep comparable to physiological NREM sleep through interaction with the GABAA receptor. Additionally, tenuigenin demonstrated improvements in sleep disturbances in MPTP-induced PD mice, suggesting its potential as a sleep-promoting substance, particularly for PD patients experiencing sleep disturbances. [Display omitted] •Tenuigenin increased the count number of NREM sleep and shortened sleep latency in mice.•Tenuigenin induced a type of NREM sleep similar to physiological NREM sleep.•Tenuigenin increased c-Fos positive cells and excited sleep-promoting neurons in VLPO.•Flumazenil abolished the sleep-promoting effects of tenuigenin.•Tenuigenin improved sleep disturbances in MPTP-induced PD mice.